Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 576

1.

miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.

Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH.

World J Gastroenterol. 2013 Jul 21;19(27):4289-99. doi: 10.3748/wjg.v19.i27.4289.

2.

MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.

Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR.

BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0.

3.

Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.

Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, Brant SR, Kwon JH.

Inflamm Bowel Dis. 2011 Jan;17(1):241-50. doi: 10.1002/ibd.21450. Epub 2010 Sep 1.

4.

Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.

Krissansen GW, Yang Y, McQueen FM, Leung E, Peek D, Chan YC, Print C, Dalbeth N, Williams M, Fraser AG.

Inflamm Bowel Dis. 2015 Mar;21(3):520-30. doi: 10.1097/MIB.0000000000000285.

PMID:
25628040
5.

Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.

Lin J, Welker NC, Zhao Z, Li Y, Zhang J, Reuss SA, Zhang X, Lee H, Liu Y, Bronner MP.

Mod Pathol. 2014 Apr;27(4):602-8. doi: 10.1038/modpathol.2013.152. Epub 2013 Sep 20.

6.
7.

Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.

Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, Schuit F, Vermeire S, Arijs I.

PLoS One. 2014 Dec 29;9(12):e116117. doi: 10.1371/journal.pone.0116117. eCollection 2014.

8.

Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.

Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R, Bouhnik Y, Laburthe M, Groyer A, Ogier-Denis E.

PLoS One. 2010 Oct 5;5(10). pii: e13160. doi: 10.1371/journal.pone.0013160.

9.

Identification of microRNAs associated with ileal and colonic Crohn's disease.

Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH.

Inflamm Bowel Dis. 2010 Oct;16(10):1729-38. doi: 10.1002/ibd.21267.

10.

MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH.

Gastroenterology. 2008 Nov;135(5):1624-1635.e24. doi: 10.1053/j.gastro.2008.07.068. Epub 2008 Aug 3.

PMID:
18835392
11.

Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis.

Takagi T, Naito Y, Mizushima K, Hirata I, Yagi N, Tomatsuri N, Ando T, Oyamada Y, Isozaki Y, Hongo H, Uchiyama K, Handa O, Kokura S, Ichikawa H, Yoshikawa T.

J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S129-33. doi: 10.1111/j.1440-1746.2009.06216.x.

PMID:
20586854
12.

Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology.

Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, Wang Y, Olsen J.

J Proteome Res. 2010 Feb 5;9(2):954-62. doi: 10.1021/pr9008223.

PMID:
19860486
13.

Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis.

Ranjha R, Aggarwal S, Bopanna S, Ahuja V, Paul J.

PLoS One. 2015 Nov 16;10(11):e0142869. doi: 10.1371/journal.pone.0142869. eCollection 2015.

14.

Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.

Ostvik AE, Granlund AV, Bugge M, Nilsen NJ, Torp SH, Waldum HL, Damås JK, Espevik T, Sandvik AK.

Inflamm Bowel Dis. 2013 Feb;19(2):265-74. doi: 10.1002/ibd.23034.

PMID:
22685032
15.

MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

Koukos G, Polytarchou C, Kaplan JL, Morley-Fletcher A, Gras-Miralles B, Kokkotou E, Baril-Dore M, Pothoulakis C, Winter HS, Iliopoulos D.

Gastroenterology. 2013 Oct;145(4):842-52.e2. doi: 10.1053/j.gastro.2013.07.001. Epub 2013 Jul 12.

16.

Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab.

Fujioka S, Nakamichi I, Esaki M, Asano K, Matsumoto T, Kitazono T.

J Gastroenterol Hepatol. 2014 Jun;29(6):1207-14. doi: 10.1111/jgh.12523.

PMID:
24447044
17.

Circulating MicroRNA in inflammatory bowel disease.

Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M.

J Crohns Colitis. 2012 Oct;6(9):900-4. doi: 10.1016/j.crohns.2012.02.006. Epub 2012 Feb 28.

PMID:
22386737
18.

Circulating microRNAs as biomarkers of adult Crohn's disease.

Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1038-44. doi: 10.1097/MEG.0000000000000430.

PMID:
26230660
19.

MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.

Min M, Peng L, Yang Y, Guo M, Wang W, Sun G.

Inflamm Bowel Dis. 2014 Apr;20(4):652-9. doi: 10.1097/MIB.0000000000000009.

PMID:
24583476
20.

Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.

Sipos F, Galamb O, Wichmann B, Krenács T, Tóth K, Leiszter K, Muzes G, Zágoni T, Tulassay Z, Molnár B.

Dis Markers. 2011;30(1):1-17. doi: 10.3233/DMA-2011-0758.

Supplemental Content

Support Center